Literature DB >> 9210824

Using principal-components regression to stabilize EMG-muscle force parameter estimates of torso muscles.

R E Hughes1, D B Chaffin.   

Abstract

Models for estimating muscle force from surface electromyographic (EMG) recordings require parameter estimates with low intertrial variability. The inclusion of multiple muscles in multivariate statistical models can lead to multicollinearity, especially when there are significant correlations between synergist muscles. One result of multicollinearity is that parameter estimates are very sensitive to changes in the independent variables. This study compared the parameter variability of multiple regression and principal-components regression techniques when applied to a six muscle EMG analysis of the lumbar region of the torso. Nine subjects participated. Twenty-three percent of the traditional multiple-regression parameters had incorrect signs, but none of the principal-components regression parameters did. The principal-components regression technique also produced parameter estimates having an order of magnitude smaller parameter variability. It was concluded that principal-components regression is an effective method of mitigating the effect of multicollinearity in torso EMG models.

Mesh:

Year:  1997        PMID: 9210824     DOI: 10.1109/10.594905

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

1.  Evaluation of three methods for determining EMG-muscle force parameter estimates for the shoulder muscles.

Authors:  Christopher J Gatti; Lisa Case Doro; Joseph E Langenderfer; Amy G Mell; Joseph D Maratt; James E Carpenter; Richard E Hughes
Journal:  Clin Biomech (Bristol, Avon)       Date:  2007-10-22       Impact factor: 2.063

2.  Real-time estimation of FES-induced joint torque with evoked EMG : Application to spinal cord injured patients.

Authors:  Zhan Li; David Guiraud; David Andreu; Mourad Benoussaad; Charles Fattal; Mitsuhiro Hayashibe
Journal:  J Neuroeng Rehabil       Date:  2016-06-22       Impact factor: 4.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.